Physician profile
Yi Sen Cheung
NPI 1912254731
$3,632.30
in general payments reported to CMS, 2019-2025
6 companies · $982 in 2025
The $982 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $524 · 2021: $395 · 2022: $483 · 2023: $417 · 2024: $444 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,777 · Entertainment: $64.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,776.94 |
| Entertainment | $64.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,965.16 | 2019-2025 | Total30, Precision7, Dailies |
| Coopervision INC. | $703.81 | 2021-2025 | Clariti Contact Lens, Myday Contact Lens, Biofinity Contact Lens |
| Johnson & Johnson Vision Care, INC. | $502.91 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $232.74 | 2022-2023 | Infuse |
| Glaukos Corporation | $148.51 | 2020-2025 | Photrexa Viscous and Photrexa |
| Optos, INC. | $79.17 | 2021-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Sen Cheung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.